´ëÇÑÁ¾¾ç³»°úÇÐȸ BEST of WCLC 2018 : 2019-01-12±³À°ÀÏÀÚ : 2019-01-12
±³À°Àå¼Ò : ¼¿ïµå·¡°ï½ÃƼ ±×·£µåº¼·ë ¹éµÎ(5F)
±³À°ÁÖÁ¦ :
BEST of WCLC 2018ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-735-2857
À̸ÞÀÏ :
KSMO1@KSMO.OR.KR ±³À°Á¾·ù : ³»°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ 50,000 / ÀüÀÓÀÇ 30,000 / ±âŸ 70,000¿ø´çÀϵî·Ï : Àü¹®ÀÇ 60,000 / ÀüÀÓÀÇ 40,000 / ±âŸ 80,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-12 Room A 08:50~09:30 Raising the Bar of Immunotherapy with Pembrolizumab ¾ÈÁø¼®(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 01-12 Room A 09:30~09:50 Lung cancer screening through imaging ±¸Áø¸ð(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 01-12 Room A 09:50~10:10 Perspectives for lung cancer early diagnosis ·ùÁ¤¼±(ÀÎÇÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 01-12 Room A 10:10~10:30 Advanced lung cancer ÀÌ°æ¿ø(°æ»ó´ëÇб³º´¿ø)
±³À°½Ã°£ 01-12 Room A 10:30~10:50 RT and Immunotherapy ³ë¿À±Ô(¾ÆÁÖ´ëÇб³º´¿ø)
±³À°½Ã°£ 01-12 Room A 10:50~11:20 Biology of the lung cancer ½ÉÈ¿¼·(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 01-12 Room A 11:30~12:30 Latest clinical updates with denosumab in cancer patients TBD(TBD)
ÈÞ½Ä 01-12 12:30~13:00 Coffee Break ()
±³À°½Ã°£ 01-12 Room A 13:00~13:20 Improving outcomes in locoregional NSCLC ¼ÛâÈÆ(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 01-12 Room A 13:20~13:40 IO for locoregioanl NSCLC ÀÓ¼±¹Î(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 01-12 Room A 13:40~14:00 Management of N2 NSCLC ¹ÚÀαÔ(¼¿ï´ëÇб³º´¿ø)
Åä·Ð 01-12 14:00~14:20 Discussion ()
±³À°½Ã°£ 01-12 Room A 14:20~14:50 Small cell lung cancer ¹ÚÁöÇö(°Ç±¹´ëÇб³º´¿ø)
±³À°½Ã°£ 01-12 Room A 14:50~15:20 Mediastinal tumors ÃÖÀ±Áö(°í·Á´ë¾È¾Ïº´¿ø)
Åä·Ð 01-12 Room A 15:20~15:30 Discussion ()
±³À°½Ã°£ 01-12 Room A 16:00~16:20 Immune checkpoint inhibitors, single or combination Á¤Çö¾Ö(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 01-12 Room A 16:20~16:40 Immuno-biomarker testing, controversies PD-L1, TMB, DNA markers È«¼÷Èñ(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 01-12 Room A 16:40~17:00 How to overcome drug resistances to EGFR TKIs ¾ÈÈñ°æ(°¡Ãµ´ë±æº´¿ø)
Åä·Ð 01-12 Room A 17:00~17:10 Discussion ()